Evidence map›Paper›PMID 34384483›Full record

ArticleIsrael journal of health policy research2021

Substances use between early and later stages of the COVID-19 pandemic in Israel.

Hagit Bonny-Noach, Keren Cohen-Louck, Inna Levy

Open access · goldAbstract read
In one paragraph

Article in Israel journal of health policy research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Epidemiology and Disease Burden of Alcohol Associated Liver Disease.Journal of clinical and experimental hepatology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hagit Bonny-NoachDepartment of Criminology, Ariel University, Ariel, Israel. hagitbo@gmail.com.ORCID 0000-0002-5092-520X
Keren Cohen-LouckDepartment of Criminology, Ariel University, Ariel, Israel.
Inna LevyDepartment of Criminology, Ariel University, Ariel, Israel.
Ariel University · ILZefat Academic College · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsOnly several empirical studies have examined substance use during the COVID-19 pandemic in general populations. Most of these studies compared self-reported substances use before the pandemic and during the pandemic's early stages. This study aims to identify the changes in substance use between the early and later waves of the COVID-19 pandemic in Israel.

methodsA cross-sectional online survey recruited 750 participants (ages 18-65) in two waves: (1) 427 during and following the first lockdown (April-mid-May, 2020); and (2) 323 following the second lockdown (from October to mid-November, 2020).

resultsParticipants who experienced two lockdowns reported more frequent consumption of all alcoholic beverages and cannabis in the last 30 days than those who experienced one lockdown. After controlling for demographic variables, significant differences were found between participants who experienced one lockdown and those who experienced two lockdowns in the consumption of alcoholic beverages (F(1, 742) = 6.90, p = .01, η

conclusionsThere is a significant association between pandemic duration and alcohol consumption. Policymakers and practitioners should develop national alcohol and cannabis use prevention and harm reduction interventions during pandemics with a focus on men, singles and youth.

Indexed as

COVID-19AdolescentAdultAgedAge FactorsAlcohol DrinkingCross-Sectional StudiesFemaleHumansIsraelMaleMarijuana UseMiddle AgedSex FactorsSubstance-Related DisordersSurveys and QuestionnairesAlcoholCannabisCOVID-19IsraelSubstance use

Identifiers

PMID34384483
PMCPMC8359629
OpenAlexW3191556589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.